28.06.2022
Transitional phase from 1 July 2022 to 31 August 2022
24.06.2022
Spikevax®: Swissmedic launches rolling review procedure for a vaccine candidate adapted to SARS-CoV-2 variants (mRNA-1273.214)
14.06.2022
First application reviewed by all five Access Consortium Authorities
10.06.2022
Swissmedic publishes Annual Report 2021
31.05.2022
Pfizer Schweiz AG has submitted an application for a new dosage recommendation for Comirnaty® paediatric vaccine
30.05.2022
Information on the status of ongoing corrective actions
26.05.2022
Entry into force of the new Ordinance on In vitro Diagnostic Medical Devices (IvDO) and amendment of the Ordinance on Clinical Trials with Medical Devices (CTO-MedD)
18.05.2022
Swissmedic is reviewing application from Moderna Switzerland GmbH
12.05.2022
Swissmedic training courses
06.05.2022
15,228 reports of suspected adverse vaccination reactions evaluated
04.05.2022
Swissmedic is issuing an urgent warning regarding slimming products and other supposedly natural products
01.05.2022
Clarifications on the prioritisation and fast-tracking of pandemic medicinal products and on the patient information requirements
12.04.2022
The Agency for Therapeutic Products has reviewed the application and approved the extension
08.04.2022
14,624 reports of suspected adverse vaccination reactions evaluated
05.04.2022
Swissmedic procedure for public consultation on ICH Guidelines
01.04.2022
Swissmedic recommends cooperation with established aid organisations
23.03.2022
ZL_00_020e_WL / ZL106_00_002e_FO
11.03.2022
13,388 reports of suspected adverse vaccination reactions evaluated
08.03.2022
Private individuals should support Ukraine via aid organisations
25.02.2022
Overview of new authorisations 2021